Clínica Baviera, S.A. (LON:0GWJ)

Market Cap	710.38M +21.6%
Revenue (ttm)	276.12M +11.0%
Net Income	39.57M +17.5%
EPS	2.40 +17.6%
Shares Out	n/a
PE Ratio	18.21
Forward PE	n/a
Dividend	1.10 (2.51%)
Ex-Dividend Date	Jun 10, 2026

Volume	n/a
Open	52.80
Previous Close	52.00
Day's Range	52.20 - 52.80
52-Week Range	40.20 - 62.00
Beta	0.75
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 25, 2026

About Clínica Baviera

Clínica Baviera, S.A., a medical company, provides ophthalmologic medicine services in Spain, Germany, and rest of Europe. The company offers refractive, presbyopia, and cataract surgeries; and oculoplastia, corneal disease, dry eye, strabismus, pediatric ophthalmology, glaucoma, neuro-ophthalmological, disorders, and blepharoplasty treatments. It also provides external and internal consultations, surgery treatments, and rehabilitation services. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and changed its name to Clínic...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1992
• Employees: 2,009
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0GWJ

Financial Performance

In 2025, Clínica Baviera's revenue was 304.91 million, an increase of 14.75% compared to the previous year's 265.72 million. Earnings were 42.06 million, an increase of 4.62%.

Financial numbers in EUR

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 10, 2026

Data Sources Report a data error